Literature DB >> 9559832

Synergistic activity of trovafloxacin and ceftriaxone or vancomycin against Streptococcus pneumoniae with various penicillin susceptibilities.

D P Nicolau, P R Tessier, R Quintiliani, C H Nightingale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9559832      PMCID： PMC105591          DOI： 10.1128/AAC.42.4.991

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  8 in total

1.  Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.

Authors:  G V Doern; A Brueggemann; H P Holley; A M Rauch
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

2.  Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacin.

Authors:  N R Cutler; J Vincent; S S Jhee; R Teng; T Wardle; G Lucas; L C Dogolo; J J Sramek
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

3.  Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae.

Authors:  Y S Kim; Q Liu; L L Chow; M G Täuber
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

Review 4.  Multiply-resistant pneumococcus: therapeutic problems in the management of serious infections.

Authors:  P D Lister
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995       Impact factor: 3.267

Review 5.  Antibiotic-resistant pneumococci.

Authors:  J R Schreiber; M R Jacobs
Journal:  Pediatr Clin North Am       Date:  1995-06       Impact factor: 3.278

Review 6.  Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review.

Authors:  C C John
Journal:  Clin Infect Dis       Date:  1994-02       Impact factor: 9.079

7.  Appearance of resistance to beta-lactam antibiotics during therapy for Streptococcus pneumoniae meningitis.

Authors:  M Muñoz; E S Valderrabanos; E Diaz; J J Silva; J A Soult; P Infante; J D Lopez; A Garcia-Curiel
Journal:  J Pediatr       Date:  1995-07       Impact factor: 4.406

8.  In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis.

Authors:  A E Girard; D Girard; T D Gootz; J A Faiella; C R Cimochowski
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191
  8 in total
  4 in total

1.  Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically achievable in cerebrospinal fluid.

Authors:  F Fitoussi; C Doit; P Geslin; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

2.  Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.

Authors:  P Cottagnoud; F Acosta; M Cottagnoud; K Neftel; M G Täuber
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

3.  Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.

Authors:  D Rodoni; F Hänni; C M Gerber; M Cottagnoud; K Neftel; M G Täuber; P Cottagnoud
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

4.  Vancomycin acts synergistically with gentamicin against penicillin-resistant pneumococci by increasing the intracellular penetration of gentamicin.

Authors:  P Cottagnoud; M Cottagnoud; M G Täuber
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.